A highly skilled and team-oriented senior scientist in gene therapy with 15 years of experience in ocular research and development. Pre-clinical research includes multiple disease areas including retinitis pigmentosa, age-related macular degeneration, and glaucoma across multiple routes of administration including sub-retinal (SR), intravitreal (IVT) and suprachoroidal (SCS) delivery. Pharmaceutical industry experience includes research project management with direct CRO and contractor management with the goal of IND enabling data, development of IVT and SCS platforms, in vivo testing of viral (AAV) and non-viral (lipid and polymer-based nanoparticles) gene therapy vectors, team lead for ELN (Benchling) implementation, and internal in vivo ocular team surgical and imaging training. Species expertise includes mice, minipig and non-human primates with extensive in-life data interpretation and analysis.